"Is Underutilization of Adjuvant Therapy in Resected Non-small Cell Lung Cancer Associated with Socioeconomic Disparities?"
Jorge Humberto Rodriguez QuinteroMohamed K KamelRajika JindaniRoger ZhuPatricia FriedmannMarc VimolratanaNeel P ChudgarBrendon StilesPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2023)
AT underutilization in patients with resected stage II-III NSCLC is associated with patient, institutional and socioeconomic factors. It is critical to implement measures to address these inequities, especially in light of newer adjuvant immunotherapy and targeted therapy treatment options which are expected to improve survival.